- Investigator
- Dominick J Angiolillo
- Status
- Accepting Candidates
- Ages
- N/A
- Sexes
- All
Research at a glance
Top areas of exploration
- Platelet Aggregation Inhibitors , 384 publications
- Percutaneous Coronary Intervention , 191 publications
- Clopidogrel , 184 publications
- Ticlopidine , 158 publications
Research activity
Active clinical trials
My publications
Filter publications
766 publications
2023
How is pharmacogenetics changing clinical trial design for percutaneous coronary intervention?
Expert Review of Clinical Pharmacology
Publisher's site2023
Immature Platelet Fraction Predicts Adverse Events in Patients With Acute Coronary Syndrome: the ISAR-REACT 5 Reticulated Platelet Substudy
Arteriosclerosis, Thrombosis, and Vascular Biology
Publisher's site2023
Impact of evolocumab on the pharmacodynamic profiles of clopidogrel in patients with atherosclerotic cardiovascular disease: a randomised, double-blind, placebo-controlled study.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
PubMed • Publisher's site2023
Influence of body weight and body mass index on the chronic pharmacokinetic and pharmacodynamic responses to clinically available doses of ticagrelor in patients with chronic coronary syndromes.
Vascular pharmacology
PubMed • Publisher's site2023
Long-Term Clopidogrel Monotherapy After Percutaneous Coronary Intervention: Will the Pupil Surpass the Master?
Journal of the American College of Cardiology
PubMed • Publisher's site